$99.50
4.314.53%
Last update: Nov 4, 12:16 PM
Edwards Lifesciences Corp
EWNYSE
The average analyst price target for Edwards Lifesciences is $101.04, 1.5% above the current price. Of 20 analysts, 18 rate it Buy and 2 Hold. Targets range from $81 to $113. The latest change came on Nov 4, 2026, when Truist Securities upgraded Edwards Lifesciences from Hold to Buy and moved its price target from $95 to $113.
Price Target Range — 9 Quarters
Analyst Consensus — 20 Analysts
Rating Trend — Last 9 Months
